-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

612.P1.58 612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I

Acute Lymphoblastic Leukemia: Clinical Studies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Tim J Peterson, PharmD1*, Andrew Lin, PharmD, BCOP1*, Patrick Hilden, MS2*, Sean Devlin, PhD2*, Nelly G. Adel, PharmD, BCOP, BCPS1* and Jae H Park, MD3

1Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Gary J Schiller, MD1, Lloyd E. Damon, MD2*, Wendy Stock, MD3, Steven E Coutre, MD4, Pamela Hsu5*, Lucy Prasad5* and Dan Douer, MD6

1University of California, Los Angeles, CA
2Department of Medicine, Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
3University of Chicago Medical Center, Chicago, IL
4Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
5spectrum pharmaceuticals, irvine
6Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

David S Shulman, MD1*, Preeti Mehrotra, MD2*, Neeraj K. Surana, MD, PhD2*, Traci M. Blonquist, MS3*, Lewis B. Silverman, MD4 and Andrew E. Place, MD, PhD5

1Boston Children's Hospital, Boston, MA
2Division of Infectious Diseases, Boston Children's Hospital, Boston, MA
3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
4Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
5Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA

Roel Polak, MD1*, Marc B Bierings, MD PhD2, Rob Pieters, MD, PhD1,3, Miranda Buitenhuis, PhD2* and Monique L. Den Boer, PhD1

1Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
2Department of Hematology and Immunology, Wilhelmina Children's Hospital, Utrecht, Netherlands
3Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Catriona Anne Parker, PhD1*, Marie Reeves, MSc1*, Sharon Love, MSc2*, Jeremy Hancock, PhD3*, Peter M Hoogerbrugge, MD, PhD4, Rosemary Sutton5*, Tom Revesz, MD6* and Vaskar Saha, PhD, FRCP, FRCPath1,7,8

1Children's Cancer Group, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom
2Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
3Bristol Genetics Laboratory, Southmead Hospital, Bristol, United Kingdom
4Prinsess Máxima Center for Pediatric Oncology, De Bilt, Netherlands
5Molecular Diagnostics, Children’s Cancer Institute Australia, Sydney, Australia
6Clinical Haematology/Oncology, Children, Youth & Women's Health Service, Adelaide, Australia
7Tata Translational Cancer Research Centre, Kolkata, India
8Tata Medical Center, Kolkata, India

Koji Sasaki, MD1, Paul B. Koller, MD2, Hagop M. Kantarjian, MD3, Deborah A Thomas, MD3, Maria R. Khouri4*, Guillermo Garcia-Manero, MD3, Rebecca Garris3*, Jorge E. Cortes, MD3, Heather Schroeder3*, Jad Chahoud, MD5, Tapan Kadia, MD3, Farhad Ravandi, MD3, Srdan Verstovsek, MD, PhD3, Naval Daver, MD3, Nitin Jain, MD3, Marina Konopleva, MD, PhD6, Susan O'Brien, MD3 and Elias Jabbour3

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
5University of Texas Hosuton Health Science Center, Houston, TX
6Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Bruce Bostrom, MD1, Bhoopatiraju Sweta2* and S. Jill James, Ph.D.3*

1Pediatric Oncology, Children's Hospitals & Clinics of Minnesota, Minneapolis, MN
2Children's Hospitals and Clinics of Minnesota, Minneapolis, MN
3Research Institute, Arkansas Children’s Hospital, Little Rock, AR

Bob de Rooij, MSc1*, Roel Polak, MD1*, Rob Pieters, MD, PhD2 and Monique L. Den Boer, PhD1

1Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
2Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Jad Chahoud, MD1, Hagop M. Kantarjian, MD2, Guillermo Garcia-Manero, MD2, Koji Sasaki, MD2, Tapan Kadia, MD2, Jorge E. Cortes, MD2, Maria R. Khouri3*, Farhad Ravandi, MD2, Jenny Dahl, PA4*, Alessandra Ferrajoli, MD2, Jovitta Jacob, RN2*, Naveen Pemmaraju, MD2, Naval Daver, MD2, Rebecca Garris2* and Elias Jabbour2

1University of Texas Hosuton Health Science Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Hesham Eissa, MD1, Yinmei Zhou, MS2*, John C Panetta, PhD3*, Emily Browne, RN, MSN, CPNP4*, Sima Jeha, MD1, Dario Campana, MD, PhD1,5, William E. Evans, PharmD3, Ching-Hon Pui, MD1, Mary V. Relling, PharmD3 and Hiroto Inaba, MD, PhD1

1Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
2Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
3Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN
4Department of Nursing Research, St Jude Children's Research Hospital, Memphis, TN
5Department of Pediatrics, National University of Singapore, Singapore, Singapore

Zheng Ge, MD, PhD, Min Li, MD*, Lichan Xiao, MD*, Run Zhang, MD* and Jianyong Li, MD, PhD

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Bingcheng Liu, MD*, Ying Wang, MD*, Chunlin Zhou, MD, PhD*, Hui Wei, MD, PhD*, Dong Lin, MD, PhD*, Wei Li, MD*, Kaiqi Liu*, Guangji Zhang*, Shuning Wei*, Yan Li, MD*, Benfa Gong*, Yuntao Liu*, Yingchang Mi, MD, PhD and Jianxiang Wang, MD

Chinese Academy of Medical Sciences & Peking Union Medical College,Hospital of Blood Diseases, Tianjin, China

Guopan Yu1*, Dan Xu1*, Qifa Liu, MD2, Jing Sun, MD2, Zhiping Fan1*, Qiang Wang1*, Xiaoli Liu1* and Qianli Jiang, MD, PhD2*

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China

Wanda Salzer, MD1, Michael J. Burke, MD2,3, Eric C. Larsen, MD4*, Si Chen, MS5*, Lia Gore, MD6, Joanne M. Hilden, MD6, Mignon L. Loh, MD7, Elizabeth Raetz, MD8, Naomi J. Winick, MD9, William L. Carroll, MD10, Meenakshi Devidas, PhD5 and Stephen P Hunger, MD11

1U.S. Army Medical Research and Materiel Command, Fort Detrick, MD
2Division of Hematology/Oncology/Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI
3Children's Hospital of Wisconsin, Milwaukee, WI
4Maine Children's Cancer Program, Scarborough, ME
5Department of Biostatistics, Colleges of Medicine, Public Health & Health Profession, University of Florida, Gainesville, FL
6Center for Cancer and Blood Disorders, Children's Hospital Colorado and the University of Colorado School of Medicine, Aurora, CO
7Department of Pediatrics, Benioff Children’s Hospital, University of California at San Francisco, San Francisco, CA
8Department of Pediatrics, Huntsman Cancer Institute and Primary Children's Hospital, University of Utah, Salt Lake City, UT
9University of Texas Southwestern Medical Center, Dallas, TX
10Department of Pediatrics, Perlmutter Cancer Center,, New York University Medical Center, New York, NY
11Department of Pediatrics, Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Ofir Wolach, MD1*, Kristen Stevenson, MS2*, Martha Wadleigh, MD1, Daniel J. DeAngelo, MD, PhD1, David P. Steensma, MD1, Robert J. Soiffer, MD1, Joseph H Antin, MD1, Donna S Neuberg, ScD2, Vincent T. Ho, MD1 and Richard M. Stone, MD1

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA

Aaron S Rosenberg, MD, MS1, Ann M Brunson, BS2*, Theresa HM Keegan, PhD, MSc2*, Joseph Tuscano, MD3, Ted Wun, MD4 and Brian Jonas, MD, PhD5

1Comprehensive Cancer Center, University of California, Davis, Sacramento, CA
2University of California, Davis, Sacramento, CA
3University of California Davis, Sacramento, CA
4Division of Hematology and Oncology, University of California – Davis School of Medicine, Sacramento, CA
5UC Davis Comprehensive Cancer Center, Sacramento, CA

*signifies non-member of ASH